Abfero Pharmaceuticals is Drug Discovery in United States that focus on genetic conditions business. Founded in 2016. They cover business area such as provider, oral iron chelator therapy, patient, systemic iron overload, transfusion, genetic condition, treatment, age-relate macular degeneration, neurodegenerative disease, compound, small molecule, metal, severe organ damage, death.
2016
( 8 years old in 2024 )
Genetic Conditions
-
405 Waltham Street
Suite 353
Lexington, MA 02421
United States
Private
provideroral iron chelator therapypatientsystemic iron overloadtransfusiongenetic conditiontreatmentage-relate macular degenerationneurodegenerative diseasecompoundsmall moleculemetalsevere organ damagedeath
* We use standard office opening hours in near Abfero Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Abfero Pharmaceuticals is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Abfero Pharmaceuticals business is focusing on Genetic Conditions.
Abfero Pharmaceuticals headquarter office and corporate office address is located in 405 Waltham Street Suite 353 Lexington, MA 02421 United States.
Abfero Pharmaceuticals was founded in United States.
In 2024, Abfero Pharmaceuticals is currently focus on genetic conditions sector.
Above is snippet of Google Trends for "genetic conditions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Abfero Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
